267 related articles for article (PubMed ID: 25346302)
21. Epidermolysis Bullosa Acquisita-Current and Emerging Treatments.
Tešanović Perković D; Bukvić Mokos Z; Marinović B
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769788
[TBL] [Abstract][Full Text] [Related]
22. Bullous pemphigoid associated with milia, increased serum IgE, autoantibodies against desmogleins, and refractory treatment in a young patient.
Ding S; Deng Q; Xiang Y; Chen J; Huang J; Lu J
An Bras Dermatol; 2017; 92(5 Suppl 1):34-36. PubMed ID: 29267440
[TBL] [Abstract][Full Text] [Related]
23. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita).
Ujiie H; Iwata H; Yamagami J; Nakama T; Aoyama Y; Ikeda S; Ishii N; Iwatsuki K; Kurosawa M; Sawamura D; Tanikawa A; Tsuruta D; Nishie W; Fujimoto W; Amagai M; Shimizu H;
J Dermatol; 2019 Dec; 46(12):1102-1135. PubMed ID: 31646663
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory epidermolysis bullosa acquisita: case report.
Fernandes MD; Chiminazzo MD; Tebcherani AJ; Aoki V; Sanchez AP
An Bras Dermatol; 2009; 84(2):181-4. PubMed ID: 19503987
[TBL] [Abstract][Full Text] [Related]
25. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
26. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune bullous skin disorders].
Hertl M; Niedermeier A; Borradori L
Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
[TBL] [Abstract][Full Text] [Related]
28. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
[TBL] [Abstract][Full Text] [Related]
29. U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study.
Barker CS; Bruner E; Self S; Elston DM
J Am Acad Dermatol; 2024 Jun; 90(6):1282-1284. PubMed ID: 38368951
[No Abstract] [Full Text] [Related]
30. Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid.
Schmidt E; Sitaru C; Schubert B; Wesselmann U; Kromminga A; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2002 Jul; 47(1):133-6. PubMed ID: 12077594
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris.
Kobayashi K; Tanaka M; Nakajima S; Ito H; Harada T; Hashimoto T
Clin Exp Dermatol; 2009 Dec; 34(8):e785-8. PubMed ID: 19778312
[TBL] [Abstract][Full Text] [Related]
32. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.
Becker M; Schumacher N; Schmidt E; Zillikens D; Sadik CD
JAMA Dermatol; 2021 Aug; 157(8):917-923. PubMed ID: 34160564
[TBL] [Abstract][Full Text] [Related]
34. Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid.
Smoller BR; Woodley DT
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):674-8. PubMed ID: 1430385
[TBL] [Abstract][Full Text] [Related]
35. Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
Gaudin O; Seta V; Alexandre M; Bohelay G; Aucouturier F; Mignot-Grootenboer S; Ingen-Housz-Oro S; Bernardeschi C; Schneider P; Mellottee B; Caux F; Prost-Squarcioni C
Front Immunol; 2018; 9():1030. PubMed ID: 29881377
[TBL] [Abstract][Full Text] [Related]
36. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
[TBL] [Abstract][Full Text] [Related]
37. Acquired skin disease of hemidesmosomes.
Zillikens D
J Dermatol Sci; 1999 Jun; 20(2):134-54. PubMed ID: 10379705
[TBL] [Abstract][Full Text] [Related]
38. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
Chan LS; Cooper KD
Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
[TBL] [Abstract][Full Text] [Related]
39. [Immunomapping in localized bullous pemphigoid].
de Jong MC; Kardaun SH; Tupker RA; Seijen HG
Hautarzt; 1989 Apr; 40(4):226-30. PubMed ID: 2659551
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
